| 000 | 03107nam a22003975i 4500 | ||
|---|---|---|---|
| 001 | 85276 | ||
| 003 | ES-MaUEC | ||
| 005 | 20230207040503.0 | ||
| 007 | cr nn 008mamaa | ||
| 008 | 160204s2016 gw | s |||| 0|eng d | ||
| 020 | _a9783319270401 | ||
| 040 | _aES-MaUEC | ||
| 050 | 4 |
_aRC435 _b2016 EB |
|
| 082 | 0 | 4 | _a615.78 |
| 245 | 1 | 0 |
_aGenetic Influences on Response to Drug Treatment for Major Psychiatric Disorders _cedited by Janusz K Rybakowski, Alessandro Serretti |
| 250 | _a1st ed. | ||
| 260 |
_aCham _bSpringer International Publishing _bImprint _bAdis _c2016 |
||
| 300 | _a1 recurso en línea (IX, 117 páginas) : | ||
| 336 |
_aTexto _btxt _2rdacontent |
||
| 337 |
_aelectrónico _bc _2rdamedia |
||
| 338 |
_arecurso electrónico _bcr _2rdacarrier |
||
| 505 | 0 | _a1. Pharmacogenetics of the Efficacy of Antipsychotic Drugs in Schizophrenia -- 2. Pharmacogenetics of Serious Antipsychotic Side-Effects -- 3. Pharmacogenetics of the Efficacy and Side Effects of Antidepressant Drugs -- 4. Genomic Studies of Treatment Resistance in Major Depressive Disorders -- 5. Complementation of Pharmacogenetics with Biomarkers and Neuroimaging in Major Depression -- 6. Pharmacogenetics of Mood Stabilizers -- 7. Practical Application of Pharmacogenetics of Antipsychotic, Antidepressant and Mood-Stabilizing Drugs. | |
| 520 | 3 | _aWritten by global experts, this book provides a modern comprehensive insight into the pharmacogenetics of treatment of major psychoses: schizophrenia, bipolar disorder and depression. The pharmacogenomics of three categories of the most important psychiatric drugs, antipsychotics, antidepressants and mood stabilizers, has been updated and reviewed. Some promising directions and perspectives for future research in pharmacogenetics in major psychoses are indicated. They are, among others, connected with the development of new methods in molecular genetics and with linking pharmacogenetics assessment with biomarkers, including neuroimaging ones. Finally, the attempts to use pharmacogenetics of antipsychotic, antidepressant and mood-stabilizing drugs in practice are presented. New pharmacogenetic tools may greatly contribute to introducing personalized medicine into psychiatric clinical practice. | |
| 710 | 2 |
_aSpringerLink (Online service) _0Local _9106996 |
|
| 942 |
_2lcc _cLE |
||
| 650 | 7 |
_aMedicina _0comprobar BNE19900959047 _2embne _9405021 |
|
| 650 | 7 |
_aGenética humana _0comprobar BNE19900986777 _2embne _9140562 |
|
| 700 | 1 |
_aRybakowski, Janusz K. _eeditor literario _998121 _0Local |
|
| 700 | 1 |
_aSerretti, Alessandro. _eeditor literario _998122 _0Local |
|
| 856 | 4 | 0 |
_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://link.springer.com/book/10.1007/978-3-319-27040-1 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid) |
| 901 | _ai9783319270401 | ||
| 907 |
_a.b12945547 _b10-10-17 _c21-11-16 |
||
| 988 | _aSpringer_Medicine_2016 | ||
| 998 |
_am _a_alco _a_vill _b - - _cm _dz _e- _feng _ggw _h0 |
||
| 945 |
_aRC435 .G464 2016 EB _g1 _ieBOOK _j0 _lmae _o- _pEUR0.00 _q- _r- _sb _t15 _u0 _v0 _w0 _x0 _y.i11589425 _z06-04-17 |
||
| 999 |
_c85276 _d85276 _x1 |
||